In Philadelphia this month, Editor in Chief Jonah Comstock spoke with Craig Ackerman, a partner at the Alexander Group, about ...

President Donald Trump has signed an executive order imposing tariffs of up to 100% on imported brandname medicines, unless ...

Each year, World Bipolar Day is an opportunity to raise awareness and deepen understanding of bipolar disorder, a condition ...

One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an initial public offering (IPO) in Hong Kong, raising HKD 2.28 billion (around $293 million). The US and Hong ...

There's no doubt that self-injection devices have transformed the lives of people with chronic diseases like diabetes, making it easier to receive treatment, whilst also reducing risks like ...

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastatic ...

Lyon, France-based late-stage clinical biotech MaaT Pharma has presented new preclinical data for MaaT034 at the American Association for Cancer Research (AACR) annual meeting 2025 in Chicago, US – ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to help ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues. The ...

Chip giant NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius, a supplier to the life sciences industry and other sectors, focusing on the design and development of 'AI factories ...

Bayer has abandoned development of its investigational P2X3 receptor antagonist eliapixant, despite promising efficacy data in clinical trials, on what appears to be safety grounds. The decision comes ...

mRNA specialist BioNTech has driven its partnership with UK artificial intelligence InstaDeep into top gear, agreeing to buy the company outright in a cash and equity deal that values it at up to £562 ...